MedTrace Logo

Treatment of Periodontitis in Menopausal Patients

NCT06254118 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-02-12

No results posted yet for this study

Summary

The goal of this clinical trial is to compare the effectiveness of polyunsaturated fatty acids (PUFAs) \[omega-3\] as an adjunctive treatment to scaling and root planing for menopausal women with periodontitis versus scaling and root alone as a non- surgical treatment .

. The main question it aims to answer is:

• to investigate the effect of systemic administration of Omega-3 fatty acids in addition to SRP on clinical periodontal parameters and GCF levels of osteocalcin and AST in menopausal women.

Participants will given \* a soft gelatin capsules containing PUFAs to be consumed directly once daily for 12 months along with non-surgical treatment (group2)

\*\* a soft gelatin capsules containing olive oil to be consumed directly once daily for 12 months along with non-surgical treatment (group1)

Researchers will compare group 1 to group 2 to see if PUFAs has an effect on clinical periodontal parameters and GCF levels of osteocalcin and AST in menopausal women. .

Conditions

  • Menopausal Patients
  • Chronic Periodontitis
  • Omega 3 Fatty Acids

Interventions

DRUG

Polyunsaturated Fatty Acids

1000mg omega-3 fatty acids taken once daily with meals for 12 months

DIETARY_SUPPLEMENT

olive oil

1000mg olive oil taken once daily with meals for 12 months

Sponsors & Collaborators

  • Hadir F. El-Dessouky

    lead OTHER

Principal Investigators

  • ELDESSOUKY · King Abdulaziz University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-22
Primary Completion
2022-01-22
Completion
2023-01-30

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06254118 on ClinicalTrials.gov